Translation, Adaptation And Validation Of The Bulgarian Version Of The SIDAED Questionnaire

1. Baker GA, Jacoby A, Buck D, Stalgis C, Monet D. Quality of life of people with epilepsy: a European study. Epilepsia. 1997;38(3):353-62.10.1111/j.1528-1157.1997.tb01128.xSearch in Google Scholar

2. Cramer JA, Brandenburg NA, Xu X, Vera-Llonch M, Oster G. The impact of seizures and adverse effects on global health ratings. Epilepsy Behav. 2007;11(2):179-84.10.1016/j.yebeh.2007.05.005Search in Google Scholar

3. Fisher RS, Vickrey BG, Gibson P, Hermann B, Penovich P, Scherer A et al. The impact of epilepsy from the patient's perspective II: views about therapy and health care. Epilepsy Res. 2000;41(1):53-61.10.1016/S0920-1211(00)00128-5Search in Google Scholar

4. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology. 2002;58(Suppl. 5):9-19.10.1212/WNL.58.8_suppl_5.S911971128Search in Google Scholar

5. Luoni C, Bisulli F, Canevini MP, De Sarro G, Fattore C, Galimberti CA, et al. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consequtively enrolled patients using validated quantitative assessments. Epilepsia. 2011;52(12):2181-91.10.1111/j.1528-1167.2011.03325.x22136077Search in Google Scholar

6. May TW, Brandt C, Kassel J. Evaluation of a self-report questionnaire for the assessment of adverse effects of antiepileptic drugs. Epilepsia. 2009;50 (Suppl 4):104.Search in Google Scholar

7. Perucca P, Carter J, Vahle V, Gilliam FG. Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy. Neurology. 2009;72(14):1223-9.10.1212/01.wnl.0000345667.45642.61267748519349601Search in Google Scholar

8. Taylor RS, Sander JW, Taylor RJ, Baker GA. Predictors of health related quality of life and costs in adults with epilepsy: a systematic review. Epilepsia. 2011;52(12):2168-80.10.1111/j.1528-1167.2011.03213.x21883177Search in Google Scholar

9. Nixon A, Kerr C, Breheny K, Wild D. Patient Reported Outcome (PRO) assessment in epilepsy: a review of epilepsy-specific PROs according to the Food and Drug Administration (FDA) regulatory requirements. Health Qual Life Outcomes. 2013;11:38.10.1186/1477-7525-11-38360636323497117Search in Google Scholar

10. Uijl SG, Uiterwaal CS, Aldenkamp AP, Carpay JA, Doelman JC, Keizer K, et al. A cross-sectional study of subjective complaints in patients with epilepsy who seem to be well-controlled with antiepileptic drugs. Seizure. 2006;15(4): 242–248.10.1016/j.seizure.2006.02.00916551504Search in Google Scholar

11. Uijl SG, Uiterwaal CS., Aldenkamp AP, Carpay JA, Doelman JC, Keizer K, et al. Adjustment of treatment increases quality of life in patients with epilepsy: a randomized controlled pragmatic trial. Eur J Neurol. 2009;16(11):1173-7.10.1111/j.1468-1331.2009.02713.x19538204Search in Google Scholar

12. Viteva EI, Zachariev ZI, Semerdzhieva MA. Validation of the Bulgarian version of the quality of life in epilepsy inventory (QOLIE-89). Folia Med. 2010;52(1):34-9.Search in Google Scholar

13. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16(3):297-334.10.1007/BF02310555Search in Google Scholar

14. Nunnally JC, Bernstein IH. Psychometric theory. 3th ed. McGraw-Hill; 1994.Search in Google Scholar

15. Carpay JA, Aldenkamp AP, van Donselaar CA. Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure. 2005;14:198-206.10.1016/j.seizure.2005.01.00815797355Search in Google Scholar